Posted in | News | Nanoelectronics

Synopsys to Validate Custom Design Solution Using TSMC’s 28nm iPDK

Synopsys, Inc. (Nasdaq: SNPS), a world leader in software and IP for semiconductor design, verification and manufacturing, today announced that it has collaborated with TSMC to validate Synopsys' custom design solution with TSMC's 28-nanometer (nm) interoperable process design kit (iPDK) and Analog/Mixed-Signal (AMS) Reference Flow 1.0. TSMC's 28nm reference phase-locked loop (PLL) design was used to validate Synopsys' comprehensive custom solution while demonstrating productivity-enhancing capabilities of the TSMC AMS Reference Flow 1.0.

The validated solution from Synopsys includes the Galaxy Custom Designer® implementation, HSPICE® circuit simulation, CustomSim™ FastSPICE simulation, StarRC™ parasitic extraction and IC Validator physical verification solutions. Through the TSMC AMS Reference Flow 1.0 validation, mutual customers can expect a comprehensive, productive and open custom design solution that helps them address the emerging challenges associated with advanced semiconductor processes.

New advanced process technology nodes, such as TSMC's 28nm process, require that EDA tools address a deeper and broader set of design challenges. These new challenges include high-accuracy SPICE models for layout-dependent effects, design-rule-driven layout with table-based design rule checking (DRC) rules, larger and more complex DRC rule sets and high-accuracy extraction. Each product in Synopsys' custom solution was validated against TSMC's AMS Reference Flow 1.0 to help ensure that customers can be more confident in meeting their design quality and timeline requirements.

"TSMC and Synopsys have been collaborating on enabling an open ecosystem for custom and analog/mixed-signal designs with iPDK," said ST Juang, senior director of design infrastructure marketing at TSMC. "The TSMC AMS Reference Flow collaboration further expands our relationship to improve the broader analog/mixed-signal and custom design solution by validating advanced TSMC technology and Synopsys tools together."

Synopsys' custom flow for front-end design and simulation consists of the Custom Designer Schematic Editor (SE) with simulation and analysis environment, HSPICE circuit simulator, CustomSim FastSPICE simulator and Custom WaveView waveform analyzer. The front-end flow was validated to meet a variety of needs such as yield, multiple process corners and noise effect analysis. The Synopsys custom physical design and verification flow consists of the Custom Designer Layout Editor (LE) with schematic-driven layout (SDL) and SmartDRD technology, IC Validator physical verification and StarRC Custom parasitic extraction. This flow was validated to address the needs of productive rule-driven layout, full DRC/LVS signoff and high-accuracy 3D extraction with RC reduction. The entire Synopsys custom flow was validated with TSMC's 28nm iPDK.

"TSMC and Synopsys have a long history of technical collaborations that provide higher design productivity and a comprehensive ecosystem for our joint customers," said Bijan Kiani, vice president of product marketing at Synopsys. "Synopsys offers a comprehensive analog/mixed-signal and custom design solution, and through this collaboration we can ensure that our mutual customers have access to a productive and streamlined flow that has been verified on the TSMC 28-nanometer process."



Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Synopsys, Inc.. (2019, March 19). Synopsys to Validate Custom Design Solution Using TSMC’s 28nm iPDK. AZoNano. Retrieved on April 24, 2024 from

  • MLA

    Synopsys, Inc.. "Synopsys to Validate Custom Design Solution Using TSMC’s 28nm iPDK". AZoNano. 24 April 2024. <>.

  • Chicago

    Synopsys, Inc.. "Synopsys to Validate Custom Design Solution Using TSMC’s 28nm iPDK". AZoNano. (accessed April 24, 2024).

  • Harvard

    Synopsys, Inc.. 2019. Synopsys to Validate Custom Design Solution Using TSMC’s 28nm iPDK. AZoNano, viewed 24 April 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.